VEGFR–GM3 Interaction in Angiogenesis
Publisher
Springer Singapore
Reference39 articles.
1. Miyake T, Kumasawa K, Sato N, Takiuchi T, Nakamura H, Kimura T (2016) Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells. Sci Rep 6:4853
2. Sallinen H et al (2009) Antiangiogenic gene therapy with soluble VEGFR-1, VEGFR-2, and VEGFR-3 reduces the growth of solid human ovarian carcinoma in mice. Mol Ther 17:278–284
3. Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 153(1):13–19
4. Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, Jeansson M, Zhang C, Tucholska M, Jones N, Kerjaschki D, Shibuya M, Fantus IG, Nagy A, Gerber HP, Ferrara N, Pawson T, Quaggin SE (2012) Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151(2):384–399
5. Svennerholm L (1980) Ganglioside and synaptic transmission. Plenum, New York